Investing. Any opinions my own.

Joined January 2022
426 Photos and videos
Pinned Tweet
$SYF Quick pitch: bank that trades at 1.25x tangible book, has de minimis deposit flight risk, & targets (earns) a 28% return on tangible equity. While perennially discounted in relation to business quality, SYF is now exceptionally cheap (less than 5x earnings).
19
13
132
86,440
Name that company.
2
5
3,128
$VBNK expects to exit '26 w/US eff. ratio <20% vs 37% in Q. Also claims 6B credit assets in bag(tipping point for scale)-ignoring RBTDs, grows to 10B in <3yrs at current rate. 3x '29 EPS if biz scales the way mgmt claims w/60% annual EPS growth thru '30. Ambitious, but maybe?
1
2
12
2,276
$TME core music-sub biz actually growing faster than SPOT's (25% CAGR vs 17%) & now 80% of the pie. What's the appropriate China discount? 9x EPS vs 40, 4x EV/EBIT vs 33, but TME probably further along monetization curve.
12
1,661
Alcohol is the new tobacco continues--Cuervo now off 70% over the last five years. What's wild is that it isn't even levered—lost 70% of its enterprise value since 2021.
11
11
118
18,408
3
3
35
9,510
$INTR is a long @$6.40. Materially oversold over past month. Hyper-growth digital banking powerhouse in Brazil trading at 7x EPS. Currently running a 15.5% ROE but guiding a 28% ROE at mid-point by 2029. If mgmt hits target, co is sub-3x 2029 EPS. ROE target highly achievable 1/n
10
7
94
10,427
Nu is more mature in its core market w/penetration at 60% of adult population, so heavy lifting is coming from newer & less proven foreign markets. Nu is also operating closer to peak efficiency, so additional operating leverage will only provide a modest tailwind to earnings.
1
2
7
1,427
$INTR has good visibility into another 300 bps of ROE expansion thru year-end. At this point, it will trade at 5.5x EPS & 4x FWD. It should also still be growing EPS at 35-40% per year. Combine this w/multiple expansion & co offers a 3-4 bag opportunity over the next few yrs.
2
12
1,634
$9435 Hikari still a great way to play value in Japan. Just ran a 30% ROE & you can buy for 1.3x materially understated book. 27' ¥2,738 EPS guide is nonsensical. Co is operating biz investments. Better framework: value like BRK:¥4,800 EPS, or 7.5x vs 13.6x based on guide. 1/n
$4389 8x EV/EBIT
2
5
65
9,675
Then to the extent that the CEO has investing skill, the investment portfolio return potentially runs higher than its look-thru earnings. Book value has continually benefitted from this: 15-year CAGR is 19% excluding dividends, 5-year CAGR is 28% when dividends are included.
1
2
1
984
A look-thru investment earnings figure of ¥150B for 2027 seems reasonable. Interest income mostly offsets interest expense. Effective tax rate is generally ~25% range. So, pay sub-8x EPS for a Japanese compounder run by an operator that actually understands capital allocation.
2
2
4
934